Invention Grant
- Patent Title: Immunotherapy for angiogenic disease
-
Application No.: US15534895Application Date: 2015-12-10
-
Publication No.: US10525096B2Publication Date: 2020-01-07
- Inventor: Haruo Sugiyama
- Applicant: International Institute of Cancer Immunology, Inc.
- Applicant Address: JP Suita-shi
- Assignee: International Institute of Cancer Immunology, Inc.
- Current Assignee: International Institute of Cancer Immunology, Inc.
- Current Assignee Address: JP Suita-shi
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2014-251208 20141211
- International Application: PCT/JP2015/084709 WO 20151210
- International Announcement: WO2016/093326 WO 20160616
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/02 ; C07K7/06 ; A61K38/17 ; A61K39/00 ; A61P27/02 ; C07K14/47 ; A61K35/17 ; C07K7/04 ; A61K9/00
Abstract:
The present invention provides a pharmaceutical composition containing a cancer antigen peptide for treatment and prevention of angiogenic diseases.
Public/Granted literature
- US20170368131A1 IMMUNOTHERAPY FOR ANGIOGENIC DISEASE Public/Granted day:2017-12-28
Information query
IPC分类:
